Alzheimer’s Disease (AD) is characterized by progressive neurodegeneration and cognitive impairment. Synaptic dysfunction is an established early symptom, which correlates strongly with cognitive decline, and is hypothesised to mediate the diverse neuronal network abnormalities observed in AD. However, how synaptic dysfunction contributes to network pathology and cognitive impairment in AD remains elusive. Here, we present a grid-cell-to-place-cell transformation model of long-term CA1 place cell dynamics to interrogate the effect of synaptic loss on network function and environmental representation. Synapse loss modelled after experimental observations in the APP/PS1 mouse model was found to induce firing rate alterations and place cell ab...
Background: Synaptic dysfunction is a major contributor to Alzheimeŕs disease (AD) pathogenesis in ...
There is a growing consensus that Alzheimer's disease (AD) involves failure of the homeostatic machi...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
Alzheimer’s disease (AD) is characterized by neuronal network dysfunction. Functional imaging studie...
Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. H...
Synapse loss has detrimental effects on cellular communication, leading to network disruptions withi...
I, Ming YI, confirm that the work presented in this thesis is my own. Where information has been der...
Alzheimer’s disease (AD) is the world’s leading cause of dementia. Proposed therapies for AD have so...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Altres ajuts: CIBERNED CB06/05/0042 i BrightFocus Foundation (A2014417S)Alzheimer's disease (AD) is ...
Synapses are points of communication between neural cells capable of neuroplastic adaptation, and th...
Clinical neuropathologic studies suggest that the selective vulnerability of hippocampal CA1 pyramid...
This is the final version of the article. Available from eLife Sciences Publications via the DOI in ...
Background Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We hav...
Background: Synaptic dysfunction is a major contributor to Alzheimeŕs disease (AD) pathogenesis in ...
There is a growing consensus that Alzheimer's disease (AD) involves failure of the homeostatic machi...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
Alzheimer’s disease (AD) is characterized by neuronal network dysfunction. Functional imaging studie...
Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. H...
Synapse loss has detrimental effects on cellular communication, leading to network disruptions withi...
I, Ming YI, confirm that the work presented in this thesis is my own. Where information has been der...
Alzheimer’s disease (AD) is the world’s leading cause of dementia. Proposed therapies for AD have so...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
Altres ajuts: CIBERNED CB06/05/0042 i BrightFocus Foundation (A2014417S)Alzheimer's disease (AD) is ...
Synapses are points of communication between neural cells capable of neuroplastic adaptation, and th...
Clinical neuropathologic studies suggest that the selective vulnerability of hippocampal CA1 pyramid...
This is the final version of the article. Available from eLife Sciences Publications via the DOI in ...
Background Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We hav...
Background: Synaptic dysfunction is a major contributor to Alzheimeŕs disease (AD) pathogenesis in ...
There is a growing consensus that Alzheimer's disease (AD) involves failure of the homeostatic machi...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...